Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of ConceptJoyce Meesters-Ensing, Stefan Nierkens, Rick Admiraal et al.|Frontiers in Pharmacology|2022Cited by 19
Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantationCoco de Koning, Stefan Nierkens, Guillermo Sanz et al.|Bone Marrow Transplantation|2021Cited by 6
High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplantRick Admiraal, Stefan Nierkens, A. Birgitta Versluijs et al.|Cytotherapy|2024Cited by 2
Predictable Fast CD4+ Reconstitution and Prevention of Graft Failure in High-Risk Patients following Cord Blood Transplantation by Individualized Dosing and Therapeutic Drug Monitoring of Anti-Thymocyte GlobulinRick Admiraal, Jaap Jan Boelens, Charlotte van Kesteren et al.|Transplantation and Cellular Therapy|2016Cited by 1
Individualized Dosing and Therapeutic Drug Monitoring (TDM) of ATG is Feasible, Safe, Effective, and Associated with Excellent Immune ReconstitutionCaroline A. Lindemans, Jaap Jan Boelens, Colin de Haar et al.|Transplantation and Cellular Therapy|2017Cited by 1